New pancreatic cancer drug sees patients live almost twice as long in clinical trial (opens in new tab)

Covers How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those treated with chemotherapy in a clinical trial.

Read the original article